AXIM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AXIM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AXIM Biotechnologies's Book Value per Share for the quarter that ended in Jun. 2024 was $-0.03.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of AXIM Biotechnologies was 45.00% per year. The lowest was -146.60% per year. And the median was -32.80% per year.
For the Biotechnology subindustry, AXIM Biotechnologies's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, AXIM Biotechnologies's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where AXIM Biotechnologies's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
AXIM Biotechnologies (OTCPK:AXIM) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of AXIM Biotechnologies's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Kurt Phinney | officer: Chief Operating Officer | 6914 MAGELLAN WAY, SARASOTA FL 34243 |
Peter O'rourke | director | C/O NORTHVIEW ACQUISITION CORP., 207 WEST 25TH STREET, 9TH FLOOR, NEW YORK NY 10001 |
Catalina Valencia | 10 percent owner | 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO CA 92121 |
Glycodots, Llc | 10 percent owner | 6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO CA 92121 |
Juniper & Ivy Corp | 10 percent owner | 5201 MEMORIAL DRIVE, SUITE 616, HOUSTON TX 77007 |
Huemoeller John Walter Ii | director | 305 SAN ANSELMO AVENUE, SUITE 300, SAN ANSELMO CA 94960 |
Blake Schroeder | director | 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111 |
Robert L Cunningham | director | 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111 |
Timothy Richard Scott | director | 5 ROCKERFELLER PLACE, 20TH FLOOR, SUITE 83, NEW YORK NY 10111 |
Robert Malasek | officer: CFO | PO BOX 235472, ENCINITAS CA 92023 |
Lekhram Changoer | 10 percent owner | 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022 |
Medical Marijuana, Inc. | 10 percent owner | 12255 CROSTHWAITE CIRCLE, POWAY CA 92064 |
Van Damme Philip A | 10 percent owner | 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022 |
Foundation Sanammad | 10 percent owner | 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022 |
George Anastassov | 10 percent owner | 18 EAST 50TH STREET, 5TH FLOOR, NEW YORK NY 10022 |
From GuruFocus
By GuruFocusNews GuruFocusNews • 06-13-2022
By GuruFocusNews GuruFocusNews • 06-02-2022
By GuruFocusNews GuruFocusNews • 04-19-2022
By GuruFocusNews GuruFocusNews • 07-03-2022
By Stock market mentor Stock market mentor • 01-17-2023
By GuruFocusNews GuruFocusNews • 05-20-2022
By PurpleRose PurpleRose • 07-21-2022
By Marketwired • 07-12-2023
By sperokesalga sperokesalga • 05-24-2023
By GuruFocusNews GuruFocusNews • 05-24-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.